Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples